Y Intercept (Hong Kong) LTD Seagen Inc. Transaction History

Y Intercept (Hong Kong) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $632,154 - $749,569	-5,386 Reduced 73.63%	1,929 $247,000
Q3 2022 Feb 14, 2023	BUY	$135.27 - $180.11 $989,500 - $1.32 Million	7,315 New	7,315 $1 Million
Q2 2021 Aug 12, 2021	SELL	$135.08 - $161.1 $1.16 Million - $1.38 Million	-8,556 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$137.51 - $190.8 $1.18 Million - $1.63 Million	8,556 New	8,556 $1.18 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.